EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 11-Jul-2025 19:10 ET (11-Jul-2025 23:10 GMT/UTC)

17-Mar-2025

Scientists gain insight into RNA-editing protein that could lead to improved treatment for cancer, autoimmune diseases

Rice University
Peer-Reviewed Publication

A research team led by Rice University’s Yang Gao has uncovered new insights into the molecular mechanisms of ADAR1, a protein that regulates ribonucleic acid (RNA) induced immune responses. Their findings, published in Molecular Cell March 17, could open new pathways for treating autoimmune diseases and enhancing cancer immunotherapy.

Journal: Molecular Cell
Funder: Welch Foundation, Cancer Prevention and Research Institute of Texas, NIH/National Institutes of Health

17-Mar-2025

Statin use and risk of hepatocellular carcinoma and liver fibrosis in chronic liver disease

JAMA Network
Peer-Reviewed Publication

About The Study: This cohort study found that statin use was associated with a reduced risk of hepatocellular carcinoma and hepatic decompensation in patients with chronic liver disease. These findings provide support for the potential role of statins in prevention of hepatocellular carcinoma and liver disease progression.

Journal: JAMA Internal Medicine

17-Mar-2025

Dr. Theodore Scott Nowicki awarded $4.5M NCI grant to advance next generation of cellular immunotherapies for solid tumors

University of California - Los Angeles Health Sciences
Grant and Award Announcement

Physician-scientist Theodore Scott Nowicki, MD, PhD, an assistant professor-in-residence of pediatric hematology/oncology and microbiology, immunology, & molecular genetics at the David Geffen School of Medicine at UCLA, has been awarded a $4.5 million R37 MERIT Award to help improve the effectiveness of cellular therapies for solid tumors.

17-Mar-2025

Impact journals to participate at the AACR Annual Meeting 2025

Impact Journals LLC
Meeting Announcement

BUFFALO, NY- March 17, 2025 – Impact Journals is pleased to announce its participation as an exhibitor at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025. The meeting is scheduled for April 25-30, 2025, at the McCormick Place Convention Center in Chicago, Illinois.

17-Mar-2025

Researchers receive $2.17 million grant to study noninvasive treatment for traumatic brain injury symptoms

Virginia Tech
Grant and Award Announcement

Funding from the National Institutes of Health will allow the team to investigate how a technique called cranial osteopathic manual manipulation might affect brain fluid motion and help balance the autonomic nervous system.

17-Mar-2025

Newly identified bacterial protein helps design cancer drug delivery system

King's College London
Peer-Reviewed Publication

Researchers have identified a previously unknown bacterial protein, the structure of which is being used in the design of protein nanoparticles for the targeted delivery of anticancer drugs to tumors.

Journal: Proceedings of the National Academy of Sciences

17-Mar-2025

Transcriptional landscape of PDAC shows distinct cell populations

Compuscript Ltd
Peer-Reviewed Publication

Pancreatic cancer is one of the leading causes of cancer-related mortality, with pancreatic ductal adenocarcinoma (PDAC) accounting for 90% of all cases. As most PDAC cases are diagnosed at advanced stages, surgical interventions are ineffective, and consequently, lymph node metastasis manifests in 70% of PDAC patients. Moreover, since the number of genetic mutations giving rise to PDAC are low, there are fewer available targeted therapeutic modalities. Analysis of gene expression at the single-cell level may help understand the tumor dynamics of PDAC.

Journal: Genes & Diseases
Funder: National Natural Science Foundation of China, National Natural Science Foundation of China, National Natural Science Foundation of China, Zhangjiang National Innovation Demonstration Zone (Shanghai, China), The Biobank Program of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine (Shanghai, China)

17-Mar-2025

SPP1+ macrophages identified as key drivers and therapeutic targets in colorectal cancer progression

Compuscript Ltd
Peer-Reviewed Publication

Colorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancer-related deaths worldwide. Despite the success of immune checkpoint blockade therapies in various solid tumors, immunotherapy for CRC remains a challenge. Hence, there is a critical need to understand the complex tumor microenvironment (TME) of CRC and identify potential targets to develop new immunotherapies.

Journal: Genes & Diseases
Funder: National Natural Science Foundation of China, Scientific and technological innovation team of Shaanxi Innovation Capability Support Plan (China), Key R&D Plan of Shaanxi Province, China

17-Mar-2025

A post-treatment blood test could inform future cancer therapy decisions

Yale University
Peer-Reviewed Publication

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with lung cancer years after their treatment.

This tool is a type of molecular residual disease (MRD)detector, which is used after patients have completed their primary treatment in order to monitor their cancer status. Researchers say it could inform clinical intervention, including whether to restart or intensify treatment.

Journal: Nature Medicine

17-Mar-2025

Newborns with heart defects may face a higher risk of developing childhood cancer

American Heart Association
Peer-Reviewed Publication

Newborns with congenital heart defects may have a higher risk of developing childhood cancer compared to children born without a heart abnormality.

Journal: Circulation